• Careers
  • Contact
  • Board of Directors

    Paul Schimmel, Ph.D.

    Board Member

    Dr. Schimmel is an Ernst and Jean Hahn Professor at The Skaggs Institute for Chemical Biology at The Scripps Research Institute. He was formerly the John D. and Catherine T. MacArthur Professor of Biochemistry and Biophysics in the Department of Biology at MIT. The Schimmel laboratory’s major research activities have concentrated on the decoding of genetic information, with emphasis on the rules of the universal genetic code which are established through aminoacylation reactions catalyzed by a group of enzymes known as aminoacyl tRNA synthetases. The latter are believed by many to be among the first enzymes to arise on this planet in the early stages of the evolution of life.  In addition to founding aTyr, Dr. Schimmel has founded or co-founded a number of groundbreaking biotechs including Alkermes, Alnylam Pharmaceuticals, Cubist Pharmaceuticals, Metabolon, Repligen Corp., Sirtris Pharmaceuticals.  He is a member of the American Academy of Arts and Sciences and the National Academy of Sciences.  Dr. Schimmel graduated from Ohio Wesleyan University, holds Ph.D. at Cornell University and MIT and did post doctoral work at Stanford University.

    print email
    © 2007 - 2017   aTyr Pharma.   Legal   Privacy Policy